Physician

Russell R Heath, MD

According to 2025 Medicare claims, Russell Heath, MD (NPI: 1649326265) practices cardiac electrophysiology in the Fort Collins-Loveland, CO market, with the plurality of this provider's patient population coming from Larimer, CO. This provider's primary affiliated billing organization is POUDRE VALLEY MEDICAL GROUP, LLC (NPI: 1366763260; TIN: 800348943) and primary practice location at 80538-9004. Heath is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Heath's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 3,625 traditional Medicare patients, billed 6,168 HCPCS/CPT codes, and received $297,529 in Medicare payments. The top billing code was 93294 (Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days). Part D data shows 1,368 prescription claims across 378 beneficiaries totaling $480,960 in drug costs, led by Eliquis (Apixaban). DME data shows 15 claims. Open Payments data shows 30 records totaling $4,544. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $93,892 to $480,960. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $27,940 to $974.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,696	3,875	$244,956
2016	1,565	3,193	$222,895
2017	1,500	3,111	$245,326
2018	1,419	3,013	$243,091
2019	1,715	3,176	$246,294
2020	1,436	2,588	$205,244
2021	1,899	3,450	$277,929
2022	1,741	3,013	$281,904
2023	2,268	3,673	$275,414
2024	3,625	6,168	$297,529

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	223	1,160	$93,892
2016	283	1,465	$174,983
2017	275	1,504	$261,079
2018	290	1,566	$319,433
2019	297	1,630	$402,520
2020	295	1,676	$429,836
2021	299	1,440	$476,211
2022	349	1,423	$478,951
2023	358	1,371	$507,710
2024	378	1,368	$480,960

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	14	$27,940
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	12	$1,062
2022	N/R	49	$3,774
2023	N/R	70	$5,136
2024	N/R	15	$974

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	565	651	$20
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	640	727	$15
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	434	450	$10
93793	Anticoagulant management of patient taking warfarin	392	488	$8
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	1,147	1,318	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	271	19,011	$368,664
Xarelto	Rivaroxaban	46	3,891	$67,974
Multaq	Dronedarone Hcl	14	840	$21,592
Flecainide Acetate	Flecainide Acetate	73	5,330	$3,871
Clopidogrel	Clopidogrel Bisulfate	179	14,467	$2,617

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	15	$974

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$1,342	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$3,202	Boston Scientific Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Russell R. Heath, MD?

Tedicare shows public-source Medicare data for Russell R. Heath, MD (NPI 1649326265), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Russell R. Heath, MD have ACO affiliation data?

Russell R. Heath, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Russell R. Heath, MD?

Russell R. Heath, MD is linked to POUDRE VALLEY MEDICAL GROUP, LLC (billing NPI 1366763260) in the available physician profile data.

Does Russell R. Heath, MD have Open Payments data?

Russell R. Heath, MD has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.